[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-336125-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-336125-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","smoking-associated-gene-expression-alterations-in-nasal-epithelium-reveal-immune-impairment-linked-to-lung-cancer-risk-research-open-access-abstract","Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk - Research Open Access Abstract","","The study examines why long-term lung cancer risk persists in former smokers by linking tobacco smoke-associated transcriptomic changes in airway tissues to immune dysfunction. Using data from 487 subjects, researchers model smoking-associated gene expression changes and test reversibility after smoking cessation. Clinic patients show persistent immune alterations, and integrating prior GWAS with a transcriptional network identifies enriched immune and interferon pathways tied to genetic risk. The work also derives a non-invasive lung cancer risk classifier from accessible airway transcriptomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/smoking-associated-gene-expression-alterations-in-nasal-epithelium-reveal-immune-impairment-linked-to-lung-cancer-risk-research-open-access-abstract/336125/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/smoking-associated-gene-expression-alterations-in-nasal-epithelium-reveal-immune-impairment-linked-to-lung-cancer-risk-research-open-access-abstract/336125.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about former smokers and lung cancer?","Question",{"text":63,"@type":64},"It investigates whether persistent smoking-associated gene expression and immune impairment explain long-term lung cancer risk after smoking cessation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the analysis conducted in the study?",{"text":68,"@type":64},"Transcriptomic data from accessible airway tissues of 487 subjects were analyzed across different smoking statuses, and a computational model assessed smoking-associated gene expression changes and reversibility after quitting.",{"name":70,"@type":61,"acceptedAnswer":71},"What key finding links immune pathways to lung cancer risk?",{"text":72,"@type":64},"Persistent immune alterations distinguish clinic patients, and integrating prior GWAS data shows strong enrichment of immune and interferon-related pathways in genes linked to genetic risk factors.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},336125,1790738755,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","de Biase etal. Genome Medicine (2024) 16:54 [https://doi.org/10.1186/s13073-024-01317-4](https://doi.org/10.1186/s13073-024-01317-4)  \nGenome Medicine  \n RESEARCH Open Access  \nSmoking-associated gene expression  \nalterations in nasal epithelium reveal immune impairment linked to lung cancer risk  \nMaria Stella de Biase 1*†, Florian Massip1,2,3,4*†, Tzu‑Ting Wei1,5, Federico M. Giorgi6,11, Rory Stark6,  \nAmanda Stone7, Amy Gladwell7, Martin O’Reilly6,12, Daniel Schütte 10, Ines de Santiago6,13, Kerstin B. Meyer6,14 , Florian Markowetz6, Bruce A. J. Ponder6*†, Robert C. Rintoul6,7,8*† and Roland F. Schwarz 1,9,10*†  \nAbstract  \nBackground Lung cancer is the leading cause of cancer‑related death in the world. In contrast to many other cancers, a direct connection to modifiable lifestyle risk in the form of tobacco smoke has long been established.  \nMore than 50% of all smoking‑related lung cancers occur in former smokers, 40% of which occur more than 15 years after smoking cessation. Despite extensive research, the molecular processes for persistent lung cancer risk remain unclear. We thus set out to examine whether risk stratification in the clinic and in the general population can be improved upon by the addition of genetic data and to explore the mechanisms ofthe persisting risk in former smokers.  \nMethods We analysed transcriptomic data from accessible airway tissues of 487 subjects, including healthy volun‑ teers and clinic patients of different smoking statuses. We developed a computational model to assess smoking‑asso‑ ciated gene expression changes and their reversibility after smoking is stopped, comparing healthy subjects to clinic patients with and without lung cancer.  \nResults We find persistent smoking‑associated immune alterations to be a hallmark of the clinic patients. Integrating previous GWAS data using a transcriptional network approach, we demonstrate that the same immune‑ and inter‑ feron‑related pathways are strongly enriched for genes linked to known genetic risk factors, demonstrating a causal relationship between immune alteration and lung cancer risk. Finally, we used accessible airway transcriptomic data to derive a non‑invasive lung cancer risk classifier.  \n\n| †Maria Stella de Biase and Florian Massip contributed equally. |\n| --- |\n| †Bruce Ponder, Robert Rintoul and Roland F. Schwarz conceived and jointly supervised the work. |\n\n*Correspondence:  \nMaria Stella de Biase[mariastella.debiase@gmail.com](mariastella.debiase@gmail.com)[ ](mariastella.debiase@gmail.com)Florian Massip  \nflorian.massip@mines‑paristech.fr Bruce A. J. Ponder [bruce.ponder@cruk.cam.ac.uk](bruce.ponder@cruk.cam.ac.uk)[ ](bruce.ponder@cruk.cam.ac.uk)Robert C. Rintoul [robert. rintoul@nhs.net](robert. rintoul@nhs.net)  \nRoland F. Schwarz  \n[roland.schwarz@iccb](roland.schwarz@iccb)‑[cologne.org](cologne.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ()[. The Creative Commons Public Domain Dedication waiver (](http://creativecommons.org/license","cbCaibdanBaXHQZ1","https://ap.wps.com/l/cbCaibdanBaXHQZ1","pdf",3116321,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What question does the study address about former smokers and lung cancer?\",\"answer\":\"It investigates whether persistent smoking-associated gene expression and immune impairment explain long-term lung cancer risk after smoking cessation.\"},{\"question\":\"How was the analysis conducted in the study?\",\"answer\":\"Transcriptomic data from accessible airway tissues of 487 subjects were analyzed across different smoking statuses, and a computational model assessed smoking-associated gene expression changes and reversibility after quitting.\"},{\"question\":\"What key finding links immune pathways to lung cancer risk?\",\"answer\":\"Persistent immune alterations distinguish clinic patients, and integrating prior GWAS data shows strong enrichment of immune and interferon-related pathways in genes linked to genetic risk factors.\"}]","Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk - Research Open Access Abstract | PDF",1790013674,48]